IBRITUMOMAB TIUXETAN

Overview

IBRITUMOMAB TIUXETAN is a Schedule H drug.
Ibritumomab treats Non-Hodgkin’s Lymphoma. Ibritumomab is a prescription medication used in patients with cancer who have been treated with chemotherapy or with rituximab and have not gotten better or have had a relapse. Ibritumomab belongs to a group of drugs called monoclonal antibodies. When combined with a radioactive substance and given with rituximab, it works as a type of radioimmunotherapy to destroy cancer cells.

Usage

IBRITUMOMAB TIUXETAN is generally used to treat: Non-Hodgkin Lymphoma

Frequently Asked Questions

Q: Is it safe on my liver?
A: Not Safe

Q: Can I take it with alcohol?
A: Check with your Doctor first

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Studies indicate Risk – Doctor advice is must

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

  • Tell your doctor and pharmacist if you are allergic to ibritumomab, any of the medications mentioned in the Ibritumomab Precautions section, any other medications, or any of the ingredients in ibritumomab injection.
  • Tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.
  • Tell your doctor if you are pregnant, plan to become pregnant or are breastfeeding.
  • If you are having surgery, including dental surgery, tell the doctor or dentist that you have received ibritumomab injection.
  • Do not have any vaccinations without talking to your doctor.
  • You should know that the radioactivity in the second dose of ibritumomab injection may be present in your body fluids for up to a week after you receive the dose.
  • You should know that ibritumomab injection contains albumin (a product that is made from live donor blood). Although there is a extremely small chance that viruses may be spread through the blood, no cases of viral diseases from this product have been reported.
  • You should know that if you receive ibritumomab injection, your body may develop antibodies (substances in the blood that help the immune system recognize and attack foreign substances) to murine proteins.

Common Side-Effects

IBRITUMOMAB TIUXETAN : Hives, Paralysis, Itchy Skin, Gums Bleeding, Cough, Dizziness, Fever, Chills, Head Headache, Lower Back Pain, Difficulty Breathing, Throat Soreness, Wheezing, Fatigue (tiredness), Pale Skin, Chest Pain, Confusion, Loose Motion, Fainting, Lightheadedness

Serious Side-Effects

IBRITUMOMAB TIUXETAN : Blood Or Red Colored Urine, Bloody Or Red Colored Stools, Bloody Or Red Colored Vomit, Vagina Bleeding, Shortness Of Breath, Eyes Blurred Vision

Rare Side-Effects

IBRITUMOMAB TIUXETAN : Coma, Seizure, Agitation, Anxiety, Back Pain, Drowsiness, Hallucinations, Restless Or Irritability, Nausea

Technical Classification

IBRITUMOMAB TIUXETAN is categorized as: CD20 MONOCLONAL ANTIBODIES / ANTINEOPLASTICS

Storage Conditions

Room Temperature (Between 15 To 25 C)

Available Alternatives

What are the other drugs with similar Ingredients?

IBRITUMOMAB TIUXETANIBRITUMOMAB TIUXETAN